Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Tigran Technologies in its new issue
Mandate

Vinge advises Tigran Technologies in its new issue

April 29, 2009

Vinge is advising Tigran Technologies AB (publ), listed on AktieTorget, in its new issue of preference shares and warrants subject to pre-emption rights for the existing shareholders.

As a result of the new issue, which is underwritten in its entirety by the principal shareholders and an external syndicate, Tigran will initially receive SEK 20 million as well as up to an additional SEK 30 million in conjunction with full exercise of the warrants.

Vinge’s team was led by Jesper Ottergren who was assisted by, among others, associates Christian Lindhé and Ida Christensson.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026